Direxion Daily Healthcare Bull 3X Shares(CURE)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 10 days
PROFIT SINCE LAST BUY
+3.66% ▲
LAST CLOSE
$154.19
10/28/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for CURE

10/28/2026: CURE (2-star) has a low Upturn Star Rating. Not recommended to BUY.

CURE is a 3x leveraged ETF designed to deliver triple the daily performance of the Health Care Select Sector Index. It is a powerful tool for short-term tactical traders seeking to capitalize on directional healthcare trends, benefiting from strong liquidity and a reputable issuer. However, it carries significant risks including volatility decay and the potential for rapid losses, making it inappropriate for long-term holding. Investors should monitor market momentum and sector-specific regulatory news closely. It is best suited for experienced traders capable of managing daily risk and who do not intend to hold the position for extended periods.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitThe fund is designed for short-term tactical trading rather than long-term growth compounding.
Momentum investorStrong fit while signal remains positiveIt is an effective tool for capturing short-term momentum in the healthcare sector when the trend is clearly positive.
Value investorWeak fitThe daily rebalancing mechanism and high costs are inconsistent with long-term value investing principles.
Dividend/Income investorWeak fitThe fund does not provide stable income and is unsuitable for income-focused portfolios.
Low-risk investorWeak fitHigh leverage and daily reset risks make this unsuitable for risk-averse investors.

Investor Profile

Ideal Investor Profile

The ideal investor is an experienced, active day trader or institutional player who understands derivative-based leverage and daily rebalancing risk.

Suitability

This ETF is strictly for short-term tactical trading and is unsuitable for long-term passive investing or buy-and-hold strategies.

Risk Profile

Risk factorLevelWhy it matters
VolatilityHighThe 3x leverage multiplier drastically amplifies price swings, potentially leading to rapid capital loss.
Market riskHighThe fund is fully exposed to the daily fluctuations of the healthcare sector.
ConcentrationHighPerformance is tied strictly to the healthcare sector, which may be impacted by specific regulatory or political risks.
Tracking/expenseHighDaily rebalancing and leverage costs result in significant tracking error over periods longer than one day.
LiquidityMediumWhile liquid, large orders may still face slippage during market turbulence.
Business/sector qualityMediumThe fund relies on the sector's general health, which is subject to reimbursement and legislative changes.

Risk Analysis

Volatility

CURE is subject to extreme volatility; its 3x leverage ensures that any move in the underlying index is tripled, often resulting in double-digit daily percentage changes.

Market Risk

The fund faces systemic sector risk, where legislative and macro-economic factors affecting healthcare providers and pharma companies directly translate into magnified portfolio risk.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
SectorHealth Care Select Sector Index — seeks 3x daily return95The fund provides concentrated exposure to US healthcare companies through derivatives to achieve 300% of the benchmark's daily movement.
Cash/collateralCash and Cash Equivalents5Cash reserves are maintained to manage margin requirements for swap contracts and daily liquidity needs.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type ETF
Historic Profit 91.43%
Avg. Invested days 55
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
ETF Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 10/28/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.